Literature DB >> 1161343

Citrullinemia: enzymatic evidence for genetic heterogeneity.

N G Kennaway, P J Harwood, D A Ramberg, R D Koler, N R Buist.   

Abstract

The specific activity of argininosuccinate synthetase (micromoles of 14CO2 per milligram of protein per hour) was 0.00104 and 0.00087 in fibroblasts derived from two patients with citrullinemia, and was undetectable in both fibroblasts and cultured lymphocytes from a third patient. In five obligate heterozygotes the specific activity in fibroblasts was 0.012-0.029 and in nine control subjects was 0.058 +/- 0.014 (0.030-0.076). In both control and patient cells, the maximum activity was obtained at pH 8.5 and there was no inhibition of normal argininosuccinate synthetase by any of the mutant cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1161343     DOI: 10.1203/00006450-197506000-00008

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

1.  Metabolism of citrulline in man.

Authors:  D Rabier; P Kamoun
Journal:  Amino Acids       Date:  1995-12       Impact factor: 3.520

2.  Intrafamilial phenotypic variability in citrullinaemia: report of a family.

Authors:  A R Issa; G Yadav; A S Teebi
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

3.  Argininosuccinate synthetase activity in cultured human lymphocytes.

Authors:  O Lockridge; E B Spector; A D Bloom
Journal:  Biochem Genet       Date:  1977-04       Impact factor: 1.890

4.  Citrullinemia: prenatal diagnosis of an affected fetus.

Authors:  L D Fleisher; C J Harris; D A Mitchell; H L Nadler
Journal:  Am J Hum Genet       Date:  1983-01       Impact factor: 11.025

5.  Acute neonatal and benign citrullinaemia in one sibship.

Authors:  E A Burgess; V G Oberholzer; J M Semmens; J Stern
Journal:  Arch Dis Child       Date:  1978-02       Impact factor: 3.791

6.  Molecular analysis of argininosuccinate synthetase deficiency in human fibroblasts.

Authors:  T S Su; H G Bock; A L Beaudet; W E O'Brien
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

7.  Complementation analysis in fibroblasts from eight patients with clinically different forms of citrullinaemia.

Authors:  N G Kennaway; H C Curtis
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

8.  Kinetic analysis of argininosuccinate synthetase in a variant form of citrullinaemia.

Authors:  I Akaboshi; F Endo; I Matsuda; T Saheki
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

9.  Citrullinaemia: the possibility of prenatal diagnosis.

Authors:  E Christensen; N J Brandt; J Philip; N G Kennaway
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

10.  Cytosolic Delivery of Argininosuccinate Synthetase Using a Cell-Permeant Miniature Protein.

Authors:  Susan L Knox; Rebecca Wissner; Samantha Piszkiewicz; Alanna Schepartz
Journal:  ACS Cent Sci       Date:  2021-03-18       Impact factor: 14.553

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.